Genera Biosystems
Genera Biosystems Ltd. is a company specializing in advanced molecular diagnostic systems, particularly multiplex qPCR technology. It is a spin-off of the Walter and Eliza Hall Medical Research Institute in Australia and is publicly traded (ASX: GBI). The company develops and markets proprietary, multiplexed molecular diagnostic tests, including Pearl-based AmpaSand technology, which is used in pathology laboratories. Genera is committed to providing clinically relevant and accurate molecular diagnostic assays to physicians and patients.
Industries
Nr. of Employees
small (1-50)
Genera Biosystems
Scoresby, Victoria, Australia, Oceania
Products
Bead-based medium-density multiplex assay platform
Bead-based multiplexing platform for medium-density diagnostic panels (approx. 5–150 analytes) suitable for pathology laboratory workflows.
Multiplex qPCR assay kits and reagents
Kits and reagents configured for multiplex qPCR workflows, validated for a range of pathogenic and research targets.
Reagent catalogue (primers, recombinant proteins, nucleic acid stains, antibodies, ELISA kits)
Commercially available validated primer sets for RT-qPCR, recombinant protein reagents, fluorescent nucleic acid stains, antibody reagents and immunoassay kits for laboratory use.
Bead-based medium-density multiplex assay platform
Bead-based multiplexing platform for medium-density diagnostic panels (approx. 5–150 analytes) suitable for pathology laboratory workflows.
Multiplex qPCR assay kits and reagents
Kits and reagents configured for multiplex qPCR workflows, validated for a range of pathogenic and research targets.
Reagent catalogue (primers, recombinant proteins, nucleic acid stains, antibodies, ELISA kits)
Commercially available validated primer sets for RT-qPCR, recombinant protein reagents, fluorescent nucleic acid stains, antibody reagents and immunoassay kits for laboratory use.
Services
Commercial distribution of validated multiplex molecular diagnostic test kits and associated reagents for pathology and diagnostic laboratories.
Provision of validated laboratory protocols and workflow recommendations for manual and automated nucleic acid extraction and RT-qPCR testing adaptable to multiple throughput levels.
Commercial sale and distribution of validated primer sets, recombinant protein reagents, fluorescent nucleic acid stains, antibody reagents and immunoassay kits for research and laboratory use.
Commercial distribution of validated multiplex molecular diagnostic test kits and associated reagents for pathology and diagnostic laboratories.
Provision of validated laboratory protocols and workflow recommendations for manual and automated nucleic acid extraction and RT-qPCR testing adaptable to multiple throughput levels.
Commercial sale and distribution of validated primer sets, recombinant protein reagents, fluorescent nucleic acid stains, antibody reagents and immunoassay kits for research and laboratory use.
Expertise Areas
- Multiplex qPCR assay development and validation
- One-step RT-qPCR protocols for clinical respiratory testing
- Nucleic acid extraction workflows (manual and automated)
- Microfluidic cartridge integration for molecular assays
Key Technologies
- Multiplex real-time PCR (qPCR)
- One-step RT-qPCR
- Probe-based qPCR assays
- Droplet digital PCR (ddPCR)
News & Updates
A bibliometric evaluation of the 100 most cited articles on ependymoma, highlighting advances in understanding the molecular biology of the disease.
Discusses the role of molecular biology in detecting genetic components related to birth defects through a three-level prevention system.
Explores chemoinformatics contributions to drug discovery using molecular descriptors and similarity principles.
Reviews genetic research on neurodegenerative diseases and the use of systems biology and genomics approaches.
Discusses immune responses triggered by damage-associated molecular patterns and pathogen-associated molecular patterns.
A bibliometric evaluation of the 100 most cited articles on ependymoma, highlighting advances in understanding the molecular biology of the disease.
Discusses the role of molecular biology in detecting genetic components related to birth defects through a three-level prevention system.
Explores chemoinformatics contributions to drug discovery using molecular descriptors and similarity principles.
Reviews genetic research on neurodegenerative diseases and the use of systems biology and genomics approaches.
Discusses immune responses triggered by damage-associated molecular patterns and pathogen-associated molecular patterns.